X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (352) 352
humans (328) 328
oncology (276) 276
male (223) 223
female (209) 209
middle aged (183) 183
lung neoplasms - drug therapy (181) 181
aged (171) 171
adult (131) 131
chemotherapy (126) 126
lung cancer (125) 125
lung neoplasms - pathology (114) 114
carcinoma, non-small-cell lung - drug therapy (107) 107
respiratory system (91) 91
cancer (90) 90
gefitinib (88) 88
lung neoplasms - genetics (82) 82
antineoplastic combined chemotherapy protocols - therapeutic use (76) 76
treatment outcome (71) 71
aged, 80 and over (70) 70
mutation (69) 69
cisplatin (67) 67
antineoplastic agents - therapeutic use (61) 61
receptor, epidermal growth factor - genetics (60) 60
lung cancer, non-small cell (59) 59
lung neoplasms - mortality (53) 53
carcinoma, non-small-cell lung - genetics (52) 52
carcinoma, non-small-cell lung - pathology (52) 52
non-small cell lung cancer (51) 51
retrospective studies (47) 47
quinazolines - therapeutic use (46) 46
cisplatin - administration & dosage (45) 45
prognosis (45) 45
hematology, oncology and palliative medicine (42) 42
pulmonary/respiratory (42) 42
survival (41) 41
survival rate (41) 41
erlotinib (40) 40
neoplasm staging (40) 40
cell line, tumor (38) 38
epidermal growth factor (38) 38
therapy (38) 38
egfr (37) 37
research (37) 37
docetaxel (36) 36
tumors (36) 36
carboplatin (35) 35
combined modality therapy (35) 35
antineoplastic combined chemotherapy protocols - adverse effects (34) 34
carcinoma, non-small-cell lung - mortality (34) 34
care and treatment (34) 34
adenocarcinoma - drug therapy (33) 33
analysis (33) 33
animals (32) 32
lung neoplasms - therapy (32) 32
non-small-cell lung cancer (32) 32
medicine, research & experimental (31) 31
trial (31) 31
antineoplastic agents - adverse effects (30) 30
mice (30) 30
adenocarcinoma (29) 29
antineoplastic agents - pharmacology (29) 29
carcinoma, small cell - drug therapy (29) 29
follow-up studies (29) 29
receptor, epidermal growth factor - antagonists & inhibitors (29) 29
adenocarcinoma - genetics (28) 28
respiratory agents (28) 28
survival analysis (28) 28
etoposide (27) 27
oncology, experimental (27) 27
camptothecin - analogs & derivatives (26) 26
carcinoma (26) 26
japan (26) 26
drug resistance, neoplasm (25) 25
expression (25) 25
lung neoplasms - metabolism (25) 25
medical colleges (25) 25
medicine & public health (25) 25
resistance (25) 25
lung neoplasms - diagnosis (24) 24
mutations (24) 24
cisplatin - adverse effects (23) 23
tomography, x-ray computed (23) 23
egfr mutation (22) 22
radiotherapy (22) 22
time factors (22) 22
acquired-resistance (21) 21
genetic aspects (21) 21
lung neoplasms - radiotherapy (21) 21
open-label (21) 21
protein kinase inhibitors - therapeutic use (21) 21
risk factors (21) 21
sensitivity (21) 21
tumor cells, cultured (21) 21
adenocarcinoma - pathology (20) 20
combination (20) 20
disease-free survival (20) 20
immunohistochemistry (20) 20
metastasis (20) 20
quinazolines - pharmacology (20) 20
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Internal medicine (Tokyo, Japan), ISSN 0918-2918, 06/2019, Volume 58, Issue 11, pp. 1625 - 1627
We herein report a case of the beneficial effect of osimertinib readministration in non-small-cell lung cancer (NSCLC) harboring an epidermal growth factor... 
Epidermal growth factor | Salvage | Epidermal growth factor receptors | Clonal deletion | Lung cancer | Case reports | Deletion | Mutation | Growth factors | Smoking | non-small cell lung cancer | EGFR T790M | osimertinib | Case Report | readministration
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2013, Volume 14, Issue 7, pp. 590 - 598
Summary Background Currently, crizotinib is the only drug that has been approved for treatment of ALK -rearranged non-small-cell lung cancer (NSCLC). We aimed... 
Hematology, Oncology and Palliative Medicine | FUSION | GENE | ONCOLOGY | C-MET | KINASE | CRIZOTINIB | ANAPLASTIC LYMPHOMA | INHIBITOR | ROS1 | Carcinoma, Large Cell - drug therapy | Lung Neoplasms - drug therapy | Prognosis | Follow-Up Studies | Carcinoma, Squamous Cell - genetics | Carcinoma, Squamous Cell - metabolism | Humans | Lung Neoplasms - metabolism | Middle Aged | Male | Immunoenzyme Techniques | Adenocarcinoma - metabolism | Receptor Protein-Tyrosine Kinases - antagonists & inhibitors | Adult | Female | Piperidines - pharmacokinetics | Adenocarcinoma - genetics | Carcinoma, Large Cell - genetics | Lung Neoplasms - genetics | Protein Kinase Inhibitors - pharmacokinetics | Carcinoma, Large Cell - metabolism | Carcinoma, Non-Small-Cell Lung - genetics | Carcinoma, Non-Small-Cell Lung - metabolism | Receptor Protein-Tyrosine Kinases - metabolism | Adenocarcinoma - drug therapy | Maximum Tolerated Dose | Carcinoma, Squamous Cell - drug therapy | Receptor Protein-Tyrosine Kinases - genetics | Piperidines - therapeutic use | Protein Kinase Inhibitors - therapeutic use | Gene Rearrangement | Carbazoles - pharmacokinetics | Aged | Carbazoles - therapeutic use | Carcinoma, Non-Small-Cell Lung - drug therapy | Neoplasm Staging | Care and treatment | Oncology, Experimental | Research | College teachers | Lung cancer, Non-small cell | Drug approval | Cancer | Index Medicus
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 07/2010, Volume 28, Issue 20, pp. 3299 - 3306
Journal Article
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2017, Volume 18, Issue 7, pp. 874 - 886
Journal Article
Scientific Reports, ISSN 2045-2322, 12/2018, Volume 8, Issue 1, pp. 1955 - 11
Journal Article
Experimental Cell Research, ISSN 0014-4827, 03/2014, Volume 322, Issue 1, pp. 168 - 177
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 10/2004, Volume 22, Issue 19, pp. 3860 - 3867
Purpose The role of adjuvant chemotherapy in patients with resected non-small-cell lung cancer (NSCLC) remains to be defined. This study was aimed at... 
SURGERY | UFT | THERAPY | ONCOLOGY | BIAS | CLINICAL-TRIALS | STAGE-I | Carcinoma, Non-Small-Cell Lung - therapy | Reproducibility of Results | Chemotherapy, Adjuvant - adverse effects | Humans | Survival Rate | Treatment Outcome | Combined Modality Therapy | Lung Neoplasms - therapy | Randomized Controlled Trials as Topic | Index Medicus
Journal Article
Journal Article
Journal Article
Cancer Letters, ISSN 0304-3835, 2011, Volume 309, Issue 2, pp. 228 - 235
Highlights ► Pemetrexed-resistant non-small cell lung cancer cell lines have not been reported. ► They remained sensitive to docetaxel, vinorelbine,... 
Hematology, Oncology and Palliative Medicine | Resistance | Thymidylate synthase | Pemetrexed | Non-small cell lung cancer | CARBOPLATIN | REDUCED FOLATE CARRIER | ANTIFOLATE | CHEMOTHERAPY | LY231514 | CISPLATIN PLUS GEMCITABINE | ONCOLOGY | RANDOMIZED PHASE-III | EXPRESSION | Cell Proliferation | Taxoids - pharmacology | Adenocarcinoma of Lung | Guanine - analogs & derivatives | Humans | Lung Neoplasms - metabolism | Immunoblotting | Adenocarcinoma - metabolism | Vinblastine - analogs & derivatives | Guanine - pharmacology | Thymidylate Synthase - biosynthesis | Adenocarcinoma - genetics | Antineoplastic Agents - pharmacology | Phosphoribosylglycinamide Formyltransferase - genetics | Camptothecin - analogs & derivatives | Lung Neoplasms - genetics | Gene Expression | Carcinoma, Non-Small-Cell Lung - genetics | Carcinoma, Non-Small-Cell Lung - metabolism | Docetaxel | Cisplatin - pharmacology | Reverse Transcriptase Polymerase Chain Reaction | Tetrahydrofolate Dehydrogenase - biosynthesis | Thymidylate Synthase - genetics | Irinotecan | Drug Resistance, Neoplasm - genetics | Glutamates - pharmacology | Cell Line, Tumor | Fluorouracil - pharmacology | Vinblastine - pharmacology | Camptothecin - pharmacology | Folic Acid Antagonists - pharmacology | Vinorelbine | Tetrahydrofolate Dehydrogenase - genetics | Lung cancer, Non-small cell | Fluorouracil | Chemotherapy | Dihydrofolate reductase | Drug therapy | Cancer therapies | Lung cancer | Index Medicus
Journal Article
Journal Article
Gan to kagaku ryoho. Cancer & chemotherapy, ISSN 0385-0684, 06/2014, Volume 41, Issue 6, p. 687
Journal Article
19.